)
Visual
test
M1 Kliniken
M1 Kliniken (M12) investor relations material
M1 Kliniken Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary18 Nov, 2025
Executive summary
Achieved strong EBIT growth of 11% and earnings per share of €0.86 for the first nine months of 2025, driven by efficiency measures and expansion of medical capacities.
Strategic focus on becoming the world's leading vertically integrated provider of medical aesthetics, including the sale of HAEMATO Pharm GmbH.
Financial highlights
Group revenue increased by 6.7% to €274.3 million year-over-year; EBITDA rose 9% to €28.2 million.
EBIT grew 11% to €24.5 million, with an EBIT margin of 8.9%; EBT up 10% to €24.4 million.
Earnings per share reached €0.86, up from €0.77 in the prior year period.
Outlook and guidance
Plans to expand the clinic network nationally and internationally, targeting €200–300 million EBIT by 2029 with a sustainable EBIT margin of at least 20%.
Continued focus on establishing the brand as a global leader in aesthetic medicine.
Trading segment EBIT decline drivers
What is the strategic rationale for HAEMATO Pharm sale?
Clarify the 2029 revenue target vs. current
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebSCSC
Q2 FY26 saw 2.5% sales growth, margin pressure, and reduced full-year guidance. - 5 FebMT
Net income rose to $3.2bn in 2025, with $6.5bn EBITDA and strong shareholder returns. - 5 FebEMBC
Q1 FY26 saw stable revenue, higher net income, improved margins, and reaffirmed guidance. - 5 FebRMR
Q1 2026 net income rose 91% to $12.2M, with strong incentive fees and high liquidity. - 5 FebLIN
Record EPS, strong cash flow, and 6–9% 2026 growth outlook driven by clean energy and capital returns. - 5 FebMKL
Operating income hit $3.2B, with improved insurance profitability and broad-based growth. - 5 FebAPOLLOTYRE
Record revenue, profit growth, major expansion, and improved financial metrics in Q3 FY26. - 5 FebSHEL
$18.5B earnings, $26.1B free cash flow, and $22B+ returned to shareholders in 2025. - 5 FebQGEN
2025 results surpassed guidance; 2026 targets strong growth and margin expansion. - 5 FebBIXT
Polysaccharide antivirals blocking galectin show rapid, broad efficacy and near-term commercialization.
Next M1 Kliniken earnings date
Q1 20261 Jun, 2026
M1 Kliniken
Next M1 Kliniken earnings date
Q1 20261 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
M1 Kliniken AG is a prominent provider of beauty medical health services in Germany, specializing in the aesthetic and surgical field. The company operates under the brand "M1 Med Beauty" across more than 35 specialist centres, offering a wide range of beauty medical treatments. The company's services extend to liposuction, eyebrow lifting, wrinkle and lip treatments, and tummy tuck surgery among other aesthetic and surgical treatment services. The company is headquartered in Berlin, Germany, and its shares are listed on the ETR.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage